Clinical, tumor, and product features associated with outcomes after axicabtagene ciloleucel therapy in follicular lymphomaSoumya Poddar, Sattva S. Neelapu, Justin A. Budka et al.|Journal of Clinical Investigation|2025Cited by 1
Impact of Inflammation, Tumor and Product Attributes on Clinical Outcomes in Patients with Relapsed/Refractory Follicular Lymphoma Treated with Axicabtagene CiloleucelSoumya Poddar, Sattva S. Neelapu, Jiali Yan et al.|Blood|2024Cited by 0